Coronary artery bypass graft in a patient with Fabry's disease

Hiroaki Osada1, Naoki Kanemitsu1, Masahisa Kyogoku2

  • 1Department of Cardiovascular Surgery, Mitsubishi Kyoto Hospital, 1 Katsuragoshomachi, Nishikyo-ku, Kyoto, 615-8087, Japan.

Insights

Fabry disease, a rare genetic disorder, can affect the heart. This case highlights the unusual occurrence of coronary artery disease in an elderly patient with Fabry disease.

Area of Science:

  • Genetics
  • Metabolic Disorders
  • Cardiology

Background:

  • Fabry disease is a lysosomal storage disorder caused by alpha-galactosidase A deficiency.
  • This deficiency leads to the buildup of ceramide trihexoside within cells.
  • Cardiac involvement is common, but coronary artery disease is a rare manifestation.

Observation:

  • A 72-year-old male patient with Fabry disease presented with left main coronary artery disease.
  • The case involved a detailed examination of the arterial wall pathology in this rare clinical scenario.

Findings:

  • The study focuses on the arterial wall pathology in a patient with Fabry disease and left main coronary artery disease.
  • This highlights the complex interplay between genetic metabolic disorders and cardiovascular manifestations.

Implications:

  • Understanding arterial wall pathology in Fabry disease is crucial for managing coronary artery disease in affected individuals.
  • This case contributes to the limited literature on cardiovascular interventions in Fabry disease patients.
  • Further research is needed to elucidate the specific mechanisms driving coronary artery disease in Fabry disease.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
937
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
395